Live Webinar: “Patients derived organoids (PDOs) to model therapy response ex vivo”

Join us on Thursday, June 7th for an informational webinar by Somaieh Hedayat of The Institute of Cancer Research. She will discuss different approaches to recapitulate the metastatic niche and compare PDOs drug responses observed in the laboratory ex vivo with clinical responses observed in patients and how those techniques will allow the study of PDO drug responses in the pre-clinical setting strengthening their value as a platform for drug screening, discovery and development.

About Somaieh Hedayat: Somaieh Hedayat is working towards a PhD on how the tissue microenvironment can affect the response of metastatic colorectal cancer cells to antiangiogenic therapies. Prior to beginning her PhD, she spent 10 years working as a Higher Scientific Officer (HSO) in the Drug Discovery Unit on target validation and cancer biomarker projects. After gaining experience in in vivo and ex vivo biology, she decided to adjust her career path slightly and in 2016 embarked on a PhD.

By |2018-06-14T19:46:01+00:00May 30th, 2018|Categories: Upcoming Events|0 Comments

Leave A Comment